secwatch.observer — SEC 8-K summary
======================================

Issuer:     Odyssey Health, Inc. (ODYY)
CIK:        0001626644
Form:       8-K
Filed at:   2023-12-13T23:59:59+00:00
Accession:  0001683168-23-008821
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Odyssey Health shareholders approve asset sale to Oragenics for $1M cash + 8M shares
--------------------------------------------------------------------------------

- Stockholders voted 45,032,700 for, 382,191 against the asset sale to Oragenics.
- $1M total cash consideration: $500k paid on signing, second $500k paid after shareholder approval on Dec 11.
- Upon closing, Odyssey will receive 8M shares of Oragenics Convertible Preferred Class F stock (1:1 conversion to common).
- Transaction expected to close before end of 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626644/000168316823008821/0001683168-23-008821-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626644/000168316823008821/odyssey_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-008821

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer